Charmaine Gittleson BSc, MBBch

Dr. Charmaine Gittleson is a senior executive with international experience as a pharmaceutical physician and enterprise manager in pharmaceutical drug development, governance, and risk management.

During her 15-year tenure with global ASX-listed specialty biotechnology company CSL, Dr. Gittleson had accountability for clinical research, medical safety, medical and patient-related ethics for development and on market programs, providing leadership in strategic product development, planning, and implementation across multiple therapeutic and rare disease areas. She also held a range of leadership roles including as a senior director, head of safety and clinical development in Melbourne, vice president of clinical strategy and senior vice president of clinical development in Pennsylvania, and chief medical officer in Melbourne. She retired from corporate roles in 2020.